Cuenta regresiva para las ENT al 2025

patient undergoing renal dialysis in South East Asia

Tracking progress to reduce premature NCD deaths by 2030

NCD Countdown is a partnership between the World Health Organization (WHO), The Lancet, NCD Alliance, the WHO Collaborating Centre on NCD Surveillance, Epidemiology, and Modelling at Imperial College London, and a global community of researchers and practitioners.

Tracking progress towards SDG target 3.4, it provides impartial evaluation of progress made by governments, multinational organisations, and donors in preventing and controlling NCDs, raising public awareness, and informing evidence-based advocacy.

In 2015, world leaders committed to achieving the United Nations' Sustainable Development Goal (SDG) 3.4: reducing premature deaths from four key noncommunicable diseases (NCDs)—cancer, cardiovascular disease, chronic respiratory disease, and diabetes—by one third among individuals aged 30 to 70 by 2030, through enhanced prevention, treatment, and the promotion of mental health and well-being.

A health worker uses the mVacciNation mobile app to record vaccination data Mozambique

Data for accountability and informed policymaking

Every two years, NCD Countdown 2030 publishes country-specific data on SDG target 3.4, detailing mortality rates between ages 30 and 70 from cancers, diabetes, cardiovascular diseases, and chronic respiratory diseases, as well as rates of decline in these diseases.

It also presents broader mortality data for all NCDs from ages 0 to 80, supporting a more inclusive approach to global health policy.

Publications

To date, NCD Countdown 2030 has published three significant reports, with a fourth report expected in 2025:

The Pandemic Sub-National Reference Laboratory at the Jose B. Lingad Memorial Regional Hospital in San Fernando City, Pampanga on 9 May 2020

2025

The study shows that while around 80% of countries experienced declines in NCD mortality from 2010 to 2019, the pace of improvement was generally slower than in the previous decade (2001-2010), driven by weaker reductions in most regions, particularly for some NCDs.

Read the report

Patients speak with a health professional at an integrated care clinic in the Dominican Republic.

2022

This report highlights efficient interventions requiring an additional US$18 billion annually (2023-2030), potentially averting 39 million deaths and generating a net economic benefit of $2.7 trillion globally ($390 per capita).

Read the report

2020

This publication outlined achievable scenarios for every country to meet SDG 3.4, emphasising that no country can achieve the target by addressing only one disease. It states, "Achieving SDG target 3.4 is ambitious but every country has one or more pathways to achieve the target by 2030."

Read the report

A doctor checks an older man's eyes for cataracts at the Julia Hospital Jamkhed India

2018

The initial report assessed global trends, demonstrating significant challenges faced by low- and middle-income countries. It strongly influenced international discussions on accelerating NCD prevention and control.

Read the report

Explore more

Anuncios

La mayoría de los países puede reducir las muertes por ENT en un tercio para el 2030, según estudio